Matches in Nanopublications for { ?s ?p "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 89 of
89
with 100 items per page.
- NP92513.RAXYeV35wQhgdkwar3d4PKGEnrXBqXKmGtwTzTzdWAV-4130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP92513.RAXYeV35wQhgdkwar3d4PKGEnrXBqXKmGtwTzTzdWAV-4130_provenance.
- NP92595.RAYUTdQNLrF8PzUTRQz79uuetuhNX0F6OD7o2uGf40T1Q130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP92595.RAYUTdQNLrF8PzUTRQz79uuetuhNX0F6OD7o2uGf40T1Q130_provenance.
- NP92596.RASYDL26gtqSjhvcWWPdbEPOAqVAC5uwvFxnsmkYH4QUE130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP92596.RASYDL26gtqSjhvcWWPdbEPOAqVAC5uwvFxnsmkYH4QUE130_provenance.
- NP92637.RAc2VH6kc80xZoI5aMfc5cTzSQZUBXE0oKvGIXIWXwpBc130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP92637.RAc2VH6kc80xZoI5aMfc5cTzSQZUBXE0oKvGIXIWXwpBc130_provenance.
- NP89163.RArgzy_9FNI6DmYvm7echQWm25HohmiPgOXKTuIQgGVic130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP89163.RArgzy_9FNI6DmYvm7echQWm25HohmiPgOXKTuIQgGVic130_provenance.
- NP89230.RAsJ56GXhnH6zFrcF9wYqM6OJcnLCwHcb73GwqLcUDXZE130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP89230.RAsJ56GXhnH6zFrcF9wYqM6OJcnLCwHcb73GwqLcUDXZE130_provenance.
- NP89449.RAvoEGxVOePAFZBLYL8qz6CEOaAbu9q1HXaYeaCugXANE130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP89449.RAvoEGxVOePAFZBLYL8qz6CEOaAbu9q1HXaYeaCugXANE130_provenance.
- NP89454.RAtPwoEOsXHmuCIsAX_p0MTVx04B_vevw_N26XsClABHw130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP89454.RAtPwoEOsXHmuCIsAX_p0MTVx04B_vevw_N26XsClABHw130_provenance.
- NP89977.RAjtKTfOke4udn0P_5TXl-ga3ET5GO6d-_phWlr2We6zk130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP89977.RAjtKTfOke4udn0P_5TXl-ga3ET5GO6d-_phWlr2We6zk130_provenance.
- NP83490.RAPMjBGUeec1Zp4u-E1O3jQWfRIJ36ZsF_pZ44yJRc8qM130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP83490.RAPMjBGUeec1Zp4u-E1O3jQWfRIJ36ZsF_pZ44yJRc8qM130_provenance.
- NP83644.RAKz8gy3b1VOxA1U0rkV6IkLG6ta5wggq3YHsv11x9OIw130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP83644.RAKz8gy3b1VOxA1U0rkV6IkLG6ta5wggq3YHsv11x9OIw130_provenance.
- NP83672.RAJzCck3MMBZFW33DPFwohttOUGNsXOrpesIk7Nc-L8h8130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP83672.RAJzCck3MMBZFW33DPFwohttOUGNsXOrpesIk7Nc-L8h8130_provenance.
- NP85247.RABXtNdSAcZdB5C6DBqOvq1yPM_Fhma2D_HHO-HxskHaI130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP85247.RABXtNdSAcZdB5C6DBqOvq1yPM_Fhma2D_HHO-HxskHaI130_provenance.
- NP91596.RAA7i1Vqopz03tqCyiYzI1YwcSShD6Ad_9_PAC7TTzRzY130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP91596.RAA7i1Vqopz03tqCyiYzI1YwcSShD6Ad_9_PAC7TTzRzY130_provenance.
- NP92608.RACcFR06JOXVNPca49qG5yllyB_P6i5iY4XJ2wkUgGP2Q130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP92608.RACcFR06JOXVNPca49qG5yllyB_P6i5iY4XJ2wkUgGP2Q130_provenance.
- NP82898.RAypJpa1mmOW9PFI6LATQk7Q26PUiESwCSEn5ZfAj9DOA130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP82898.RAypJpa1mmOW9PFI6LATQk7Q26PUiESwCSEn5ZfAj9DOA130_provenance.
- NP83038.RA8lmUZpb3x9azQj5mLSeKcGWnxi48LwMpHVAkpGGbmuM130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP83038.RA8lmUZpb3x9azQj5mLSeKcGWnxi48LwMpHVAkpGGbmuM130_provenance.
- NP83489.RAx2FDfDT1wKgiS67N88Wq3z88lbKiXPcWJYoObTzTEDE130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP83489.RAx2FDfDT1wKgiS67N88Wq3z88lbKiXPcWJYoObTzTEDE130_provenance.
- NP83542.RAwJ2X9zjPFc3QsoQ3p0RHtVpRQujvnV_07ByUTx3aegY130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP83542.RAwJ2X9zjPFc3QsoQ3p0RHtVpRQujvnV_07ByUTx3aegY130_provenance.
- NP83623.RA91h728gm7StF3AY9gr6etozNmGp2rBKSa0ef5ycwbSE130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP83623.RA91h728gm7StF3AY9gr6etozNmGp2rBKSa0ef5ycwbSE130_provenance.
- NP83640.RA5Q38VwWzr4lzHL5ONCQjJvmgAThRHOorJBBbeUGLqlM130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP83640.RA5Q38VwWzr4lzHL5ONCQjJvmgAThRHOorJBBbeUGLqlM130_provenance.
- NP83753.RA4y7bQjyCtjtGW9c_Tx5jw8kb34McDIhjatT1tDg3-Po130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP83753.RA4y7bQjyCtjtGW9c_Tx5jw8kb34McDIhjatT1tDg3-Po130_provenance.
- NP83910.RAxpXop276Vv8mfqPaLIXTGddYJE28L-p2vjV2JsKsSHU130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP83910.RAxpXop276Vv8mfqPaLIXTGddYJE28L-p2vjV2JsKsSHU130_provenance.
- NP83944.RA9Dp-OqAn60WAWn9LHv2LE7lCCi97oNAxk-8PYRKnuDg130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP83944.RA9Dp-OqAn60WAWn9LHv2LE7lCCi97oNAxk-8PYRKnuDg130_provenance.
- NP84144.RA9Bp2ggNQXdwwCA_JgPJZ0sEV2X7A11s1fqrUFg20-20130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP84144.RA9Bp2ggNQXdwwCA_JgPJZ0sEV2X7A11s1fqrUFg20-20130_provenance.
- NP84169.RA1f8g3rCzjOw91PojtqDu7oRodfts0HUGAxSBGsmbmn4130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP84169.RA1f8g3rCzjOw91PojtqDu7oRodfts0HUGAxSBGsmbmn4130_provenance.
- NP84551.RA-VoLvJdgZby1S4Kr06j6Jlijas_X_a9FS0nNxQRDjRg130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP84551.RA-VoLvJdgZby1S4Kr06j6Jlijas_X_a9FS0nNxQRDjRg130_provenance.
- NP85165.RA6PNHYkcA9WMvmeBkaFb2k-r_K0pDPlZcB_YJrb801Do130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP85165.RA6PNHYkcA9WMvmeBkaFb2k-r_K0pDPlZcB_YJrb801Do130_provenance.
- NP86996.RAxC0zp6FpBlylMes_rYPTqAlsB0u4FCI8VlSqlJP_o3g130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP86996.RAxC0zp6FpBlylMes_rYPTqAlsB0u4FCI8VlSqlJP_o3g130_provenance.
- NP87160.RA5I4bbnTQyxp4RNTd5LblTnuT1E1me0jtztOQKoXl9Eg130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP87160.RA5I4bbnTQyxp4RNTd5LblTnuT1E1me0jtztOQKoXl9Eg130_provenance.
- NP87901.RA0tZ7CJgGMPzt0JhOv2FYMJyeoOI6BSoxF4K9Rpgt548130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP87901.RA0tZ7CJgGMPzt0JhOv2FYMJyeoOI6BSoxF4K9Rpgt548130_provenance.
- NP89461.RAwL0m54LYA0Od60G9sxwd9jNyr-VwUByhZlqGnj8Lkms130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP89461.RAwL0m54LYA0Od60G9sxwd9jNyr-VwUByhZlqGnj8Lkms130_provenance.
- NP90492.RAx-VnZSx3gP3rqZlnCV9PvIcPHBAikgNdgvPbEks0ok8130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP90492.RAx-VnZSx3gP3rqZlnCV9PvIcPHBAikgNdgvPbEks0ok8130_provenance.
- NP90535.RA_D2Wp2fCFDfWJuwjOHmVPJwGrdfnLgayw5NXp_O5DwY130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP90535.RA_D2Wp2fCFDfWJuwjOHmVPJwGrdfnLgayw5NXp_O5DwY130_provenance.
- NP90735.RA0mSIUIdtRDZwqTfy-QbdbCxHOTVQOgvJKntPcsZz97k130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP90735.RA0mSIUIdtRDZwqTfy-QbdbCxHOTVQOgvJKntPcsZz97k130_provenance.
- NP91050.RA9rA95d-FOhpfQh1vosZtUt6--BSakGuWJBzMGaHUlA8130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP91050.RA9rA95d-FOhpfQh1vosZtUt6--BSakGuWJBzMGaHUlA8130_provenance.
- NP91107.RA44clxVqTjYrRrX9o9lnxXuVqG1FmeIfPd_A4iZfd-Rg130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP91107.RA44clxVqTjYrRrX9o9lnxXuVqG1FmeIfPd_A4iZfd-Rg130_provenance.
- NP91319.RA4AmalQfeD_C59XkKPeN78uWTnlJzoSdU6JtZEOsONiU130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP91319.RA4AmalQfeD_C59XkKPeN78uWTnlJzoSdU6JtZEOsONiU130_provenance.
- NP91617.RA41MiY_ByQAO93Vy0jQXWyyhy2T9bDCptm9P9kGeYTQY130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP91617.RA41MiY_ByQAO93Vy0jQXWyyhy2T9bDCptm9P9kGeYTQY130_provenance.
- NP85205.RAX2BDLx6883MCJ3rdmSGvloCU8c2KA-dBlqftF9cl0BM130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP85205.RAX2BDLx6883MCJ3rdmSGvloCU8c2KA-dBlqftF9cl0BM130_provenance.
- NP85213.RASyeKmWPHit1CWkfopspWAvOIarddVwTw2dbI0qzD7b8130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP85213.RASyeKmWPHit1CWkfopspWAvOIarddVwTw2dbI0qzD7b8130_provenance.
- NP85480.RAbLwIQS1WpAF1CE_2c1MReVjyqPx3wDoNK6fRrWrU8BQ130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP85480.RAbLwIQS1WpAF1CE_2c1MReVjyqPx3wDoNK6fRrWrU8BQ130_provenance.
- NP85683.RAdMVQzTKTFJBrFm2_Y81RG0SkReAKF8edl_jp-mUfJAY130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP85683.RAdMVQzTKTFJBrFm2_Y81RG0SkReAKF8edl_jp-mUfJAY130_provenance.
- NP86890.RAaLeIhySp6eHTtcWJBTPOSLgSz8p62KI3a6ZN3W0nBd0130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP86890.RAaLeIhySp6eHTtcWJBTPOSLgSz8p62KI3a6ZN3W0nBd0130_provenance.
- NP88002.RAbpkX555lJH5VFw4qydgAr90kz2Bo8vjsKe0S85C64J0130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP88002.RAbpkX555lJH5VFw4qydgAr90kz2Bo8vjsKe0S85C64J0130_provenance.
- NP89453.RAZC5DEqClh7gd5MPfKEzsNTSJC04x_RtlJVBVfpk4y44130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP89453.RAZC5DEqClh7gd5MPfKEzsNTSJC04x_RtlJVBVfpk4y44130_provenance.
- NP89675.RAc7Lam22wSbE0NegbkdPcU4EgrN_aIwOeQpDdMmbWIiQ130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP89675.RAc7Lam22wSbE0NegbkdPcU4EgrN_aIwOeQpDdMmbWIiQ130_provenance.
- NP90209.RAWJM6_BlfNfdSq2lUa0fkvWzwBBv7AYqOYmwkWpico1o130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP90209.RAWJM6_BlfNfdSq2lUa0fkvWzwBBv7AYqOYmwkWpico1o130_provenance.
- NP82934.RAYPnsATwDTMZWOT9CWW1CW9f5sGe9iSYVj8vYr0CIstI130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP82934.RAYPnsATwDTMZWOT9CWW1CW9f5sGe9iSYVj8vYr0CIstI130_provenance.
- NP83015.RAV7DpoULFJJZLl9x76-ZincMzb_RnsABURNIh5VhiCog130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP83015.RAV7DpoULFJJZLl9x76-ZincMzb_RnsABURNIh5VhiCog130_provenance.
- NP83031.RAYlwVZ2K3kOBJRt8TvyulCPGsBqGwOIPWQdoxDJ9e2gI130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP83031.RAYlwVZ2K3kOBJRt8TvyulCPGsBqGwOIPWQdoxDJ9e2gI130_provenance.
- NP92420.RA-_qsMF9DpfthdjFJnE89kvtPS0zupBGEVjK3qEC6IxA130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP92420.RA-_qsMF9DpfthdjFJnE89kvtPS0zupBGEVjK3qEC6IxA130_provenance.
- NP92560.RA6aXSLJKaXULZFtUWH-MbmD0JCftlVBOpOWeuRcrc4Dc130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP92560.RA6aXSLJKaXULZFtUWH-MbmD0JCftlVBOpOWeuRcrc4Dc130_provenance.
- NP92605.RA6KwFnimM6feDb4GicJKJUte_sEENQ9WE06f1QT9hjXk130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP92605.RA6KwFnimM6feDb4GicJKJUte_sEENQ9WE06f1QT9hjXk130_provenance.
- NP92609.RA-LxT37xAm58mGX0X2oFMFaY8Fn3-7ikoeeVPTVh0ZYI130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP92609.RA-LxT37xAm58mGX0X2oFMFaY8Fn3-7ikoeeVPTVh0ZYI130_provenance.
- NP92627.RA94i9XdAtPDXhrkKxS5ji8ZUQliPWPfBkRRy1g6E1i24130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP92627.RA94i9XdAtPDXhrkKxS5ji8ZUQliPWPfBkRRy1g6E1i24130_provenance.
- NP91236.RAQLfxUlladdB9zgu6SGA_SJat0uxa2f4I6-3bjMRwSWY130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP91236.RAQLfxUlladdB9zgu6SGA_SJat0uxa2f4I6-3bjMRwSWY130_provenance.
- NP91544.RAZF78Oee-LU2_y5qAdqNdEAXqyOiykvuhImOoacXD66Y130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP91544.RAZF78Oee-LU2_y5qAdqNdEAXqyOiykvuhImOoacXD66Y130_provenance.
- NP91621.RAfdFeHI57yqC3SOOB1BVFu-s_q7dU7aQpxdPcwFbVgXE130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP91621.RAfdFeHI57yqC3SOOB1BVFu-s_q7dU7aQpxdPcwFbVgXE130_provenance.
- NP85658.RAmQdmxWwIGoxaxVTc-8XwvtqDWnlHEN8co1Jm3bRRvmk130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP85658.RAmQdmxWwIGoxaxVTc-8XwvtqDWnlHEN8co1Jm3bRRvmk130_provenance.
- NP85660.RAljTradDYq2aI6Rm3w5H968Wzdj3sd-C9Vqehi2oXYa8130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP85660.RAljTradDYq2aI6Rm3w5H968Wzdj3sd-C9Vqehi2oXYa8130_provenance.
- NP85667.RArngi94P7-q-N_RBL4d1cx26hftE9u_ainYe2l66mS9c130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP85667.RArngi94P7-q-N_RBL4d1cx26hftE9u_ainYe2l66mS9c130_provenance.
- NP86850.RAr_E1YZ9yRqt2cRjIj2_g4Q04G8TeibLF0flBhAAMeQg130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP86850.RAr_E1YZ9yRqt2cRjIj2_g4Q04G8TeibLF0flBhAAMeQg130_provenance.
- NP86894.RAlZlgW0xV5R1kCtzJDWrZyXn4TBlUtKW9rfp8jHQUZUI130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP86894.RAlZlgW0xV5R1kCtzJDWrZyXn4TBlUtKW9rfp8jHQUZUI130_provenance.
- NP87759.RAuwmQGWOIm35W9pkBaBsV1bSYUTU0N9eWzxef_hKJFlk130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP87759.RAuwmQGWOIm35W9pkBaBsV1bSYUTU0N9eWzxef_hKJFlk130_provenance.
- NP90740.RAsl3sLg0hTUP6aUPXoFhXWG62o3Fkx2mkxs6ZvnOnLsc130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP90740.RAsl3sLg0hTUP6aUPXoFhXWG62o3Fkx2mkxs6ZvnOnLsc130_provenance.
- NP91257.RAorCo7xYvZmQYBjlYRFTwl_nEuUexKlz6z2XWS7o5QSM130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP91257.RAorCo7xYvZmQYBjlYRFTwl_nEuUexKlz6z2XWS7o5QSM130_provenance.
- NP91261.RApRzow-XO11DgzJdoEMBMovazzjGbNhLNTwilnsvNZtA130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP91261.RApRzow-XO11DgzJdoEMBMovazzjGbNhLNTwilnsvNZtA130_provenance.
- NP91357.RAjTQo8IJaUVnbza15UjL8a1PuhvRIDk8DexK2_mpos7Y130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP91357.RAjTQo8IJaUVnbza15UjL8a1PuhvRIDk8DexK2_mpos7Y130_provenance.
- NP82932.RAi_M56IjPW2dxvJIPBduM7hU1UIOLO4WWRYA92yH9sbk130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP82932.RAi_M56IjPW2dxvJIPBduM7hU1UIOLO4WWRYA92yH9sbk130_provenance.
- NP83008.RAtw8jI7JJIqGEquzfM2mzQUigGg3ocvQeZjOp1kdfcDM130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP83008.RAtw8jI7JJIqGEquzfM2mzQUigGg3ocvQeZjOp1kdfcDM130_provenance.
- NP83547.RAhogPRmVAjuPHg4fDHhRVmQtjtCtZcVSDM2nQcsDir3A130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP83547.RAhogPRmVAjuPHg4fDHhRVmQtjtCtZcVSDM2nQcsDir3A130_provenance.
- NP83939.RAtWTb4b_djqH6xg2A8fOR4dhn7Q9p_qsI6zeww4PVnJQ130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP83939.RAtWTb4b_djqH6xg2A8fOR4dhn7Q9p_qsI6zeww4PVnJQ130_provenance.
- NP85210.RAhCkJkGIsV25Q2-3FHDoOvck-cIhPPu-SO1fgGrWG9TE130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP85210.RAhCkJkGIsV25Q2-3FHDoOvck-cIhPPu-SO1fgGrWG9TE130_provenance.
- NP85244.RAiJbcuzZf87i4kLK8Z_HMm5sr6bhSpU9TafIrhVQrVIg130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP85244.RAiJbcuzZf87i4kLK8Z_HMm5sr6bhSpU9TafIrhVQrVIg130_provenance.
- NP92618.RAqQ06Oy62ySOdd9Jz0VcRU_q2MXgtRJvj0nbvxeC6sfo130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP92618.RAqQ06Oy62ySOdd9Jz0VcRU_q2MXgtRJvj0nbvxeC6sfo130_provenance.
- NP92640.RAsAJMpkEWppLDSu1-810nQQb8cdiJ-gqAIRc9rP5h0cg130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP92640.RAsAJMpkEWppLDSu1-810nQQb8cdiJ-gqAIRc9rP5h0cg130_provenance.
- NP84145.RAEvZgHKruOt48nbNcNQ_LzhLBkOZi4akcYWWAVeNwIoQ130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP84145.RAEvZgHKruOt48nbNcNQ_LzhLBkOZi4akcYWWAVeNwIoQ130_provenance.
- NP85819.RAO2mKS4V0xpdzYY5J0FsihIGmQIxhWU-j86VMsOzBbH4130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP85819.RAO2mKS4V0xpdzYY5J0FsihIGmQIxhWU-j86VMsOzBbH4130_provenance.
- NP87102.RANsMPVuDGIGyHNdZkOs-lj4Y4Yl9gZxmtWhZqwdYfe-Y130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP87102.RANsMPVuDGIGyHNdZkOs-lj4Y4Yl9gZxmtWhZqwdYfe-Y130_provenance.
- NP89416.RAEmsIQHw8jcguk6jkrb9_FR1Tes-55V6cN-g3mmnXTXg130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP89416.RAEmsIQHw8jcguk6jkrb9_FR1Tes-55V6cN-g3mmnXTXg130_provenance.
- NP90477.RAHL-dZ8lc7uq3b8UstVeWKlwK6qYBl9CC-beKV01V7-o130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP90477.RAHL-dZ8lc7uq3b8UstVeWKlwK6qYBl9CC-beKV01V7-o130_provenance.
- NP90479.RAFbXQBVkemjoZ4qI859DSnAcQx4mzRHwWx-KyWTIZXsA130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP90479.RAFbXQBVkemjoZ4qI859DSnAcQx4mzRHwWx-KyWTIZXsA130_provenance.
- NP90949.RAPI-_PhvzbdXfLkwTtTJFvZLlPaEE1KjwAAXKfIXqUns130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP90949.RAPI-_PhvzbdXfLkwTtTJFvZLlPaEE1KjwAAXKfIXqUns130_provenance.
- NP91205.RAHZPb7hYExVzmpzcvwxFgJYsb4-y1EYhVXgIp-JWxok8130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP91205.RAHZPb7hYExVzmpzcvwxFgJYsb4-y1EYhVXgIp-JWxok8130_provenance.
- NP91534.RAIl27Et2Jlt5wK3OSoLs3gG7-Hvy0CpMGShWX3_fezUo130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP91534.RAIl27Et2Jlt5wK3OSoLs3gG7-Hvy0CpMGShWX3_fezUo130_provenance.
- NP91536.RAFWPtoa6XKmVSvVHYZUyFjF-7si0FVrOkvFz-NSiCiwM130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP91536.RAFWPtoa6XKmVSvVHYZUyFjF-7si0FVrOkvFz-NSiCiwM130_provenance.
- NP91873.RAMrC1SOQJR1ntoKU95VxQki8iFgubHogn-zZrIqYjfuc130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP91873.RAMrC1SOQJR1ntoKU95VxQki8iFgubHogn-zZrIqYjfuc130_provenance.
- NP92574.RAFBlDYxiLQ7cI_vUg-ciF7_VzYbF1rymhsGZCkQhptWg130_assertion description "[We designed a custom resequencing chip that can detect known and new sequence changes in 90 retinal disease genes using a new high-throughput strategy with a high sensitivity and specificity for one tenth of the cost of conventional direct sequencing. The developed amplification strategy allows for the pooling of multiple patients with non-overlapping phenotypes, enabling many patients to be analyzed simultaneously in a fast and cost-effective manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP92574.RAFBlDYxiLQ7cI_vUg-ciF7_VzYbF1rymhsGZCkQhptWg130_provenance.